Price Crosses Moving Average
|Bid||171.26 x 1000|
|Ask||174.75 x 800|
|Day's Range||172.37 - 175.34|
|52 Week Range||135.14 - 176.62|
|Beta (5Y Monthly)||0.52|
|PE Ratio (TTM)||22.18|
|Earnings Date||Aug 01, 2023 - Aug 07, 2023|
|Forward Dividend & Yield||1.94 (1.12%)|
|Ex-Dividend Date||May 11, 2023|
|1y Target Est||188.50|
Subscribe to Yahoo Finance Plus to view Fair Value for ABCLearn more
AmerisourceBergen (ABC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.
McKesson is Wednesday's IBD Stock Of The Day. Drug distributors are hot and MCK stock is consolidating following a strong quarterly report.
For Alcon (ALC), in terms of end market, Surgical global cataract procedure growth varies significantly by region.
J.B. Hunt Transport Services, Archer-Daniels-Midland, NVIDIA, Tractor Supply and AmerisourceBergen are part of the Zacks Screen of the Week article.
Globus Medical's (GMED) REFLECT is intended to treat young children with progressive scoliosis, while preserving motion, stability and future modulated growth.
Investors are optimistic about LabCorp (LH) on strategic partnerships and upbeat guidance.
Shockwave Medical's (SWAV) latest commercial availability and the patient enrollment in its study are expected to serve a wider patient pool.
Abbott's (ABT) latest additions to Diversity in Clinical Trials effort expand upon the alliances, awards and the emphasis on diverse participation in its own clinical trials.
Veeva Systems' (VEEV) strong product portfolio raises optimism about the stock.
National Vision's (EYE) Q1 net revenues are positively impacted by the timing of unearned revenue.
Investors remain optimistic about Patterson Companies (PDCO) on the back of its broad product line.
AmerisourceBergen will repurchase about $50 million of its common stock from Walgreens in this transaction, the U.S. drugstore chain said, adding that its ownership of AmerisourceBergen's common stock would remain at 17%. The Deerfield, Illinois-based company sold AmerisourceBergen shares for $1 billion last December, cutting its ownership from 20%. The share sale has no impact on the long-term partnership between the two companies, Walgreens said.
Walgreens Boots Alliance, one of the largest U.S. pharmacies, said on Thursday it has sold some of its shares in drug distributor AmerisourceBergen Corp for $694 million and will primarily use the proceeds to pay down debt. AmerisourceBergen will repurchase about $50 million of its common stock from Walgreens in this transaction, the U.S. drugstore chain said, adding that its ownership of AmerisourceBergen's common stock would remain at 17%. The Deerfield, Illinois-based company sold AmerisourceBergen shares for $1 billion last December, cutting its ownership from 20%.
CONSHOHOCKEN, Pa., May 12, 2023--AmerisourceBergen Corporation (NYSE: ABC) today announced that it has agreed to repurchase shares of its common stock from Walgreens Boots Alliance Holdings LLC in the amount of approximately $50 million in concurrence with Walgreens Boots Alliance’s entry into certain variable pre-paid forward transactions executed in reliance on Rule 144 under the Securities Act of 1933, as amended.
NextGen's (NXGN) Behavioral Health Suite is expected to offer better access to care and improve patient outcomes.
Revvity's (PKI) first-quarter results reflect the impact of transition following divestment of AES business. While earnings outpace estimates, sales miss the same.
Fresenius Medical's (FMS) first-quarter revenues benefit from strong performances across all segments, especially the North America and Asia-Pacific regions. However, rising costs hurt margins.
Masimo's (MASI) robust product shipments and continued strength in its healthcare business drive its Q1 sales.
DaVita's (DVA) robust revenues in both segments drive its first-quarter performance.
Shockwave Medical's (SWAV) first-quarter results reflect robust revenue growth and gross margin expansion on the back of strong demand and new launches.
McKesson's (MCK) fiscal fourth-quarter 2023 results benefit from growth in the United States. Divestment hurt the International segment.
Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see...
Despite strength in Avanos' (AVNS) Chronic Care segment, its overall first-quarter results reflect soft performances.
AMN Healthcare's (AMN) dismal results in all its segments led to a soft overall Q1 performance.